Sabrina Munggarani Yusuf
Faculty of Medicine, Universitas Padjadjaran

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Bixa Orellana L Leaf infusion as an Anti-inflammatory Agent in Carrageenan-induced Wistar Rats Yusuf, Sabrina Munggarani; Rohmawaty, Enny; Nusjirwan, Rama
Althea Medical Journal Vol 1, No 2 (2014)
Publisher : Althea Medical Journal

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (712.412 KB)

Abstract

Background: One of the characteristics of inflammation is swelling or edema. Inflammation can be treated with traditional medicine, such as Bixa orellana L. Bixa orellana L leaf  contains flavonoid and tannin responsible for its anti-inflammatory effect. This study was conducted to analyse the ability of Bixa orellana L leaf infusion (BOLI) to suppress paw edema in carrageenan-induced Wistar rats.Methods: This study was conducted in the Animal Laboratory of Department of Pharmacology and Therapy Faculty of Medicine Universitas Padjadjaran in October 2012. Bixa orellana L leaves were procured from Lembang, Bandung, and were botanically identified at the Herbarium of Universitas Padjadjaran, Jatinangor. Thirty female Wistar rats were randomly divided into five groups. Group 1 was given 5 mL aquades as a control, three groups received BOLI with 0,09 g; 0,18 g; and 0,36 g dosage respectively; and group 5 was given 0,9 mg diclofenac. At 1 hour after treatment, all rats were induced by carrageenan injection subcutaneously. Paw edema changes were quantified at 0, 1, 2, 3, 4, 5, 6, and 24 hour afterwards. Data were analysed using Kruskal-Wallis and Mann-Whitney testResults: Based on paw edema inhibition percentage, 0.18 g of BOLI was shown most effective (16.97%) compared to 0.09 g (10.96%) and 0.36 g (7.50%). Interestingly, no significant differences of anti-inflammatory effect were observed between groups that were treated with 0,18 g of BOLI and diclofenac (p > 0,005).Conclusions: The BOLI can suppress inflammation comparable to diclofenac. The effective dosage is 0.18 g/200 g BW/day.[AMJ.2014;1(1):7–12]Keywords: anti-inflammatory, Bixa orellana L leaf, paw edema Infusa Daun Kesumba (Bixa Orellana L) sebagai Anti Inflamasi pada Tikus Wistar yang Diinduksi Carrageenan Latar Belakang: Salah satu ciri khas dari peradangan atau inflamasi adalah adanya pembengkakan atau edema. Peradangan dapat diobati  dengan obat tradisional, seperti Kesumba (Bixa orellana). Daun Kesumba diketahui mengandung flavonoid dan tanin yang berfungsi sebagai anti-inflamasi. Penelitian ini dilakukan untuk menganalisis kemampuan infusa daun kesumba (Bixa orellana) (BOLI) dalam mengurangi edema tungkai pada kaki tikus Wistar yang diinduksi Carrageenan.Metode: Penelitian ini dilakukan di Laboratorium Hewan Departemen Farmakologi dan Terapi di Rumah Sakit Umum Dr. Hasan Sadikin Bandung pada bulan Oktober 2012. Daun Kesumba (Bixa Orellana) diperoleh dari Lembang, Bandung, dan diidentifikasi botani di Herbarium Universitas Padjadjaran, Jatinangor. Tiga puluh tikus Wistar betina secara acak dibagi menjadi lima kelompok. Kelompok kontrol negatif diberi 5 mL aquades, tiga kelompok menerima BOLI dengan 0,09 g; 0,18 g; dan masing-masing 0,36 g dosis; sedangkan kelompok kontrol positif diberikan 0,9 mg diklofenak. Pada 1 jam setelah pengobatan, semua tikus diinduksi oleh subkutan injeksi karagenan. Perubahan edema (Paw) yang diukur pada 0, 1, 2, 3, 4, 5, 6, dan 24 jam sesudahnya. Data dianalisis denganmenggunakanKruskal-Wallis dan uji Mann-Whitney.Hasil: Berdasarkan persentase pengurangan edema tungkai, kelompok 0,18g BOLI terlihat paling efektif (16,9%) dibandingkan dengan 0,09 g (10,9%) dan 0,36 g (7,5%). Tidak ada perbedaan yang signifikan dari efek anti-inflamasi yang diamati antara kelompok-kelompok yang diobati dengan 0,18 g BOLI dan diklofenak (p> 0.005).Simpulan: Infusa Daun Kesumba (Bixaorellana) dapat menekan peradangan sama baiknya dengan diklofenak. Dosis efektif adalah 0,18 g /200 g BB / hari.Kata kunci: anti-inflamasi, daun kesumba (Bixaorellana), edema tungkai DOI: 10.15850/amj.v1n2.347
Cardiopulmonary Complications During and After Endoscopy in Elderly Patients:a Prospective Study Yusuf, Sabrina Munggarani; Dwimartutie, Noto; Maulahela, Hasan; Harimurti, Kuntjoro; Rinaldi, Ikhwan; Yunihastuti, Evy; Fauzy, Achmad; Putranto, Rudi
The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy Vol 26, No 2 (2025): VOLUME 26, NUMBER 2, AGUSTUS, 2025
Publisher : The Indonesian Society for Digestive Endoscopy

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24871/2622025120-129

Abstract

Background: The high incidence of gastrointestinal and pancreaticobiliary diseases among elderly has led to increased endoscopic procedures in this population. Previous studies indicate a higher risk of cardiopulmonary complications during and after endoscopy in elderly patients compared to younger individuals. This study investigated the incidence and contributing factors of endoscopy-related cardiopulmonary complications in elderly patients.Methods: A prospective cohort study was conducted on 194 patients aged ≥ 60 years undergoing endoscopy at the Gastrointestinal Endoscopy Center, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia, from August to October 2023. Consecutive sampling method was used. Multivariate analysis with logistic regression was conducted. Results: Among the 194 patients included, 49.52% experienced cardiopulmonary complications. The most common complications were tachycardia (23.20%), hypoxemia (15.03%), and hypotension (6.20%). Multivariate analysis identified the complexity of the procedure (ASGE level ≥ 3) as a significant risk factor (RR 1.505, 95% CI 1.039-2.179; p=0.03), while mild-moderate sedation was associated with a reduced risk of complications (RR 0.668, 95% CI 0.458-0.975; p=0,037). Conclusion: The incidence of cardiopulmonary complications during and after endoscopy is high among Indonesian elderly. Procedure complexity is an independent risk factor, whereas mild-moderate sedation mitigates the risk. In opposite, advanced age, multimorbidities, high ASA class, long duration of procedure, poor nutritional and functional status, and type of procedure did not affect outcomes